oxfordbiomedica.co.uk

OxfordBioMedica |

Skip to main content. Results, reports and presentations. Shareholder meetings, circulars and prospectuses. A video introduction to Oxford BioMedica. A video introduction to Oxford BioMedica. We are working on our own internal product candidates and have interests in a range of partner programmes. Our bioprocessing expertise and facilities support both our own and our partners’ product development. Proposed placing to raise approximately 20.5 million. 44 (0) 1865 783 000.

http://oxfordbiomedica.co.uk/

OVERVIEW OF oxfordbiomedica.co.uk

TRAFFIC RANK

>1,000,000

REVIEWS

0

PAGES IN THIS WEBSITE

14

LINKS TO THIS WEBSITE

CONTACTS

ADDRESSES

SOCIAL LINKS

ONLINE SINCE

WEBSITE DETAILS

SEO

PAGES

SIMILAR SITES

TRAFFIC RANK FOR OXFORDBIOMEDICA.CO.UK

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

September

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Friday

TRAFFIC BY CITY

Sign up

CUSTOMER REVIEWS

Average Rating: 3.9 out of 5 with 14 reviews

5 star

5

4 star

4

3 star

4

2 star

0

1 star

1

Hey there! Start your review of oxfordbiomedica.co.uk

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

LOAD TIME

0.3 seconds

FAVICON PREVIEW

16x16
32x32

CONTACTS AT OXFORDBIOMEDICA.CO.UK

ADD CONTACT

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

CONTENT

PAGES IN
THIS WEBSITE

14

SSL

EXTERNAL LINKS

65

SITE IP

85.92.92.58

LOAD TIME

0.328 sec

SCORE

6.2

PAGE TITLE

OxfordBioMedica | | oxfordbiomedica.co.uk Reviews

<META> DESCRIPTION

Skip to main content. Results, reports and presentations. Shareholder meetings, circulars and prospectuses. A video introduction to Oxford BioMedica. A video introduction to Oxford BioMedica. We are working on our own internal product candidates and have interests in a range of partner programmes. Our bioprocessing expertise and facilities support both our own and our partners’ product development. Proposed placing to raise approximately 20.5 million. 44 (0) 1865 783 000.

<META> KEYWORDS

1 fulltext search

2 apply

3 overview

4 directors and management

5 technology

6 pipeline

7 bioprocessing

8 investors

9 investors homepage

10 regulatory news

CONTENT

Page content here

KEYWORDS ON PAGE

fulltext search,apply,overview,directors and management,technology,pipeline,bioprocessing,investors,investors homepage,regulatory news,share price information,financial calendar,analyst coverage,registrars,investor contacts,corporate governance,events

SERVER

Apache

POWERED BY

PHP/5.5.21

CONTENT-TYPE

utf-8

GOOGLE PREVIEW

OxfordBioMedica | | oxfordbiomedica.co.uk Reviews

https://oxfordbiomedica.co.uk

Skip to main content. Results, reports and presentations. Shareholder meetings, circulars and prospectuses. A video introduction to Oxford BioMedica. A video introduction to Oxford BioMedica. We are working on our own internal product candidates and have interests in a range of partner programmes. Our bioprocessing expertise and facilities support both our own and our partners’ product development. Proposed placing to raise approximately 20.5 million. 44 (0) 1865 783 000.

INTERNAL PAGES

oxfordbiomedica.co.uk

1

The LentiVector<sup>®</sup> platform

http://www.oxfordbiomedica.co.uk/lentivector

Oxford BioMedica is a world leading gene and cell therapy company focused on dev…. The combined strength of our in-house development know-how, bioprocessing facili…. Oxford BioMedica was formed out of Oxford University. Oxford BioMedica is now a…. Our vision: Oxford BioMedica is a leading company in gene and cell therapy with…. Meet us - conferences. What is gene and cell therapy? Why use a lentiviral vector? The Group is developing a product which combines both its LentiVector and 5T4 technology platfor...

2

Non-Executive Directors

http://www.oxfordbiomedica.co.uk/non-executive-directors

Oxford BioMedica is a world leading gene and cell therapy company focused on dev…. The combined strength of our in-house development know-how, bioprocessing facili…. Oxford BioMedica was formed out of Oxford University. Oxford BioMedica is now a…. Our vision: Oxford BioMedica is a leading company in gene and cell therapy with…. Meet us - conferences. What is gene and cell therapy? Why use a lentiviral vector? The Group is developing a product which combines both its LentiVector and 5T4 technology platfor...

3

SAR 421869

http://www.oxfordbiomedica.co.uk/sar-421869

Oxford BioMedica is a world leading gene and cell therapy company focused on dev…. The combined strength of our in-house development know-how, bioprocessing facili…. Oxford BioMedica was formed out of Oxford University. Oxford BioMedica is now a…. Our vision: Oxford BioMedica is a leading company in gene and cell therapy with…. Meet us - conferences. What is gene and cell therapy? Why use a lentiviral vector? The Group is developing a product which combines both its LentiVector and 5T4 technology platfor...

4

5T4 Tumour Antigen

http://www.oxfordbiomedica.co.uk/5t4-tumour-antigen

Oxford BioMedica is a world leading gene and cell therapy company focused on dev…. The combined strength of our in-house development know-how, bioprocessing facili…. Oxford BioMedica was formed out of Oxford University. Oxford BioMedica is now a…. Our vision: Oxford BioMedica is a leading company in gene and cell therapy with…. Meet us - conferences. What is gene and cell therapy? Why use a lentiviral vector? The Group is developing a product which combines both its LentiVector and 5T4 technology platfor...

5

Meet us - conferences

http://www.oxfordbiomedica.co.uk/meet-us-conferences

Oxford BioMedica is a world leading gene and cell therapy company focused on dev…. The combined strength of our in-house development know-how, bioprocessing facili…. Oxford BioMedica was formed out of Oxford University. Oxford BioMedica is now a…. Our vision: Oxford BioMedica is a leading company in gene and cell therapy with…. Meet us - conferences. What is gene and cell therapy? Why use a lentiviral vector? The Group is developing a product which combines both its LentiVector and 5T4 technology platfor...

UPGRADE TO PREMIUM TO VIEW 9 MORE

TOTAL PAGES IN THIS WEBSITE

14

LINKS TO THIS WEBSITE

volantisconsulting.com

Our Clients - Volantis Consulting

http://www.volantisconsulting.com/our-clients/4536152835

Our Clients - Volantis Consulting. Volantis Consulting works with the following types of organisations:-. Start-up companies who need help with establishing their employer brand, culture, compensation and performance strategies. Small/medium-sized growing businesses who want to take their businesses to the next level. Venture capital/private equity-funded companies that need to obtain maximum return from their employee costs. To email us direct,. Mission, Vision, Values. You need Flash to use this feature.

genterapia.lap.hu

Génterápia - Vállalatok. A legjobb válaszok profiktól.

http://genterapia.lap.hu/vallalatok/25636027

Legyen a Startlap a kezdőlapom. Http:/ genterapia.lap.hu/. Advanced Cell and Gene Therapy (USA). Ezt a linket add a Startlaphoz! Amsterdam Molecular Therapeutics (NL). Ezt a linket add a Startlaphoz! BTX Harvard Apparatus (USA). Ezt a linket add a Startlaphoz! Ezt a linket add a Startlaphoz! Ezt a linket add a Startlaphoz! Copernicus Therapeutics, Inc. (USA). Ezt a linket add a Startlaphoz! Ezt a linket add a Startlaphoz! Gene Ｍedicine Japan Inc. (JP). Ezt a linket add a Startlaphoz! VirRx, Inc. (USA).

trakcel.com

Cell Therapy Traceability, Chain of Custody, chain of Identity and Risk Management

https://trakcel.com/about-us.html

Empowering Technology. Exceptional People. TrakCel delivers a suite of integrated technologies to effectively and easily orchestrate the cell therapy supply chain for autologous and allogeneic therapies - ensuring safe, scalable and affordable products. Developed in collaboration with industry leaders, TrakCel delivers the visibility and control required to safely manage Cell, Gene and Immunotherapies from Clinical Trials through to commercial scale on a global basis. Customer and Quality focused. Tokyo ...

innomedica.fi

Innomedica » References

http://www.innomedica.fi/references

Mdash; Top main menu —. Ndash; Partner in Europe. Ndash; Partner in Japan. Ndash; Market research. Ndash; Project management. Ndash; Testimonials & Case studies. Ndash; Board of Directors. Testimonials & Case studies. Testimonials & Case studies. Testimonials & Case studies. Due to the nature of our clients’ business, not all of our client references are public. Our clients include several multinational publicly traded companies. Genoscoper Laboratories, a DNA diagnostics laboratory specializes in highly...

eu.arminvestorday.com

Company Presenters | EU Advanced Therapies Investor Day

http://eu.arminvestorday.com/company-presentations

Timothy Miller, Ph.D., President, CEO and Director. Headquarters: Texas, USA. Number of Full-Time Employees: 18. Company Website: www.abeonatherapeutics.com. James Noble, Co-Founder and CEO. Headquarters: Abingdon, UK. Number of Full-Time Employees: 279. Company Website: www.adaptimmune.com. Mike Rice, President and CEO. Headquarters: Washington, USA. Number of Full-Time Employees: 45. Company Website: www.biolifesolutions.com. Linda Marban, Ph.D., Co-Founder and CEO. Headquarters: California, USA. Kiadi...

UPGRADE TO PREMIUM TO VIEW 60 MORE

TOTAL LINKS TO THIS WEBSITE

65

SOCIAL ENGAGEMENT

OxfordBioMedica

OTHER SITES

oxfordbiodynamics.com

Home | Oxford Biodynamics

Board & Governance. Chromosome conformation signatures response to methotrexate in early rheumatoid arthritis. Directors Talk highlights OBD’s achievements on ALS project. OBD presents latest ALS biomarker data at the 6th World CNS Summit. Annual Report and Accounts for the year ended 30 Sep 2017 published. Oxford BioDynamics announces grant of Indian patent for its proprietary technology platform, EpiSwitch . We are a biotechnology company with a proprietary biomarker discovery platform, EpiSwitch.

oxfordbioelectronics.com

Oxford Bioelectronics | Linking technology with physiology |

Linking technology with physiology. Pioneering advances in the emerging field of bioelectronics. Bioelectronics is an exciting new area of medicine which is transforming the way we think about and treat the human body. Advances in this pioneering field are already being tipped to rewrite the medical textbooks. Gregory B. Diette, MD, MHS. Johns Hopkins University School of medicine. Pulmonologist, Intensivist and Epidemiologist for two decades. He is a member of the American Thoracic Society. Lorem ipsum ...

oxfordbiofuels.com

Home - Oxford Biofules

Here at Oxford Biofuels Ltd, We believe in protecting the environment for "our" future generations. We recycle waste vegetable oil into carbon neutral environmentally green Biodiesel. All waste from the Biodiesel manufacturing process is sent to a anaerobic digestion plant which uses it to produce Biogas. Biogas can then be combusted to produce heat,electricity or road fuel. The solid waste is then used as fertilizer. All this from a waste product! It JUST makes sense!

oxfordbiomaterials.com

Oxfordbiomaterials Ltd

March 2018: hiring a Research Engineer- See Recruitment page. Silk for the 21st Century. Oxford Biomaterials Ltd - Magdalen Centre, Oxford Science Park, OX4 4GA, Oxford, UK.

oxfordbiomed.com

Oxford Biomedical Research | Assay Kits | Biomarker Assay

Skip to main content. Cortisol The Stress Hormone. Our immunoassay is widely used to measure cortisol in many biological fluids and has been used extensively as a biomarker for stress and to monitor adrenal function. Plasminogen Activation is Involved in Fibrinolysis, Cell Adhesion, Apoptosis, and Cell Proliferation. We offer a complete line of plasminogen activators, inhibitors, enzymes, antibodies, and assay kits. The Glutathione S-transferases: A Large Family of Enzymes with Many Roles. CypExpress is ...

oxfordbiomedica.co.uk

OxfordBioMedica |

Skip to main content. Results, reports and presentations. Shareholder meetings, circulars and prospectuses. A video introduction to Oxford BioMedica. A video introduction to Oxford BioMedica. We are working on our own internal product candidates and have interests in a range of partner programmes. Our bioprocessing expertise and facilities support both our own and our partners’ product development. Proposed placing to raise approximately 20.5 million. 44 (0) 1865 783 000.

oxfordbiomedical.co.uk

AIM Rules - OXACO PLC

Updated every 15 minutes. Share Price and RNS. Annual and Interim Reports. The following information is disclosed in accordance with Rule 26 of the AIM Rules:. Description of the business. The names of the directors and biographical details. Directors' responsibilities and Committees. Country of incorporation and main country of operation. OXACO PLC is incorporated in England and Wales (Registration Number 05845469) with England its main country of operation. Number of securities in issue. As an AIM trad...

oxfordbiomedical.com

AIM Rules - OXACO PLC

Updated every 15 minutes. Share Price and RNS. Annual and Interim Reports. The following information is disclosed in accordance with Rule 26 of the AIM Rules:. Description of the business. The names of the directors and biographical details. Directors' responsibilities and Committees. Country of incorporation and main country of operation. OXACO PLC is incorporated in England and Wales (Registration Number 05845469) with England its main country of operation. Number of securities in issue. As an AIM trad...

oxfordbiomedicalmaterials.com

AIM Rules - OXACO PLC

Updated every 15 minutes. Share Price and RNS. Annual and Interim Reports. The following information is disclosed in accordance with Rule 26 of the AIM Rules:. Description of the business. The names of the directors and biographical details. Directors' responsibilities and Committees. Country of incorporation and main country of operation. OXACO PLC is incorporated in England and Wales (Registration Number 05845469) with England its main country of operation. Number of securities in issue. As an AIM trad...

oxfordbiopatch.com

Oxford Biopatch

oxfordbiopharma.com

Oxford BioPharma

Welcome to Oxford Bio. Pharma was established in April 2005 and is a science company providing consultancy services to the biotechnology, pharmaceutical, new start up and investment communities. We offer consultancy to bio-science companies with scientific projects that are in the early stage of development and speed up the progress of these projects from feasibility status through to patenting and elevation to main project status within our partners’ organisations. Design : OSX Ltd.